The Blood Screening market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Blood Screening market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Blood Screening market.
Key players in the global Blood Screening market covered in Chapter 2 and Chapter 6:
Grifols (Spain)
Abbott Laboratories (U.S.)
Roche Diagnostics (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
BioM?rieux (France)
Bio-Rad Laboratories, Inc. (U.S.)
Beckman Coulter, Inc. (U.S.)
Siemens Healthineers (Germany)
Becton, Dickinson and Company (U.S)
Ortho Clinical Diagnostics, Inc. (U.S.)
In Chapter 8 and Chapter 10.3, based on types, the Blood Screening market from 2017 to 2029 is primarily split into:
First Generation
Second Generation
Third Generation
Fourth Generation & Above
Rapid Tests
Western Blot Assay
Next-generation Sequencing (NGS)
In Chapter 9 and Chapter 10.4, based on applications, the Blood Screening market from 2017 to 2029 covers:
Blood Banks
Hospitals
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Blood Screening market, containing global revenue and CAGR. The forecast and analysis of Blood Screening market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Blood Screening. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Blood Screening industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Blood Screening industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Blood Screening in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Blood Screening market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Blood Screening, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Blood Screening market, including the global sales and revenue forecast, regional forecast. It also foresees the Blood Screening market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Blood Screening Market Overview
1.1 Product Overview and Scope of Blood Screening
1.2 Blood Screening Segment by Type
1.2.1 Global Blood Screening Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of First Generation
1.2.3 The Market Profile of Second Generation
1.2.4 The Market Profile of Third Generation
1.2.5 The Market Profile of Fourth Generation & Above
1.2.6 The Market Profile of Rapid Tests
1.2.7 The Market Profile of Western Blot Assay
1.2.8 The Market Profile of Next-generation Sequencing (NGS)
1.3 Global Blood Screening Segment by Application
1.3.1 Blood Screening Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Blood Banks
1.3.3 The Market Profile of Hospitals
1.4 Global Blood Screening Market, Region Wise (2017-2022)
1.4.1 Global Blood Screening Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Blood Screening Market Status and Prospect (2017-2022)
1.4.3 Europe Blood Screening Market Status and Prospect (2017-2022)
1.4.3.1 Germany Blood Screening Market Status and Prospect (2017-2022)
1.4.3.2 UK Blood Screening Market Status and Prospect (2017-2022)
1.4.3.3 France Blood Screening Market Status and Prospect (2017-2022)
1.4.3.4 Italy Blood Screening Market Status and Prospect (2017-2022)
1.4.3.5 Spain Blood Screening Market Status and Prospect (2017-2022)
1.4.3.6 Russia Blood Screening Market Status and Prospect (2017-2022)
1.4.3.7 Poland Blood Screening Market Status and Prospect (2017-2022)
1.4.4 China Blood Screening Market Status and Prospect (2017-2022)
1.4.5 Japan Blood Screening Market Status and Prospect (2017-2022)
1.4.6 India Blood Screening Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Blood Screening Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Blood Screening Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Blood Screening Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Blood Screening Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Blood Screening Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Blood Screening Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Blood Screening Market Status and Prospect (2017-2022)
1.4.8 Latin America Blood Screening Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Blood Screening Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Blood Screening Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Blood Screening Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Blood Screening Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Blood Screening Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Blood Screening Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Blood Screening Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Blood Screening Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Blood Screening Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Blood Screening Market Status and Prospect (2017-2022)
1.5 Global Market Size of Blood Screening (2017-2029)
1.5.1 Global Blood Screening Revenue Status and Outlook (2017-2029)
1.5.2 Global Blood Screening Sales Status and Outlook (2017-2029)
2 Global Blood Screening Market Landscape by Player
2.1 Global Blood Screening Sales and Share by Player (2017-2022)
2.2 Global Blood Screening Revenue and Market Share by Player (2017-2022)
2.3 Global Blood Screening Average Price by Player (2017-2022)
2.4 Global Blood Screening Gross Margin by Player (2017-2022)
2.5 Blood Screening Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Blood Screening Market Competitive Situation and Trends
2.6.1 Blood Screening Market Concentration Rate
2.6.2 Blood Screening Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Blood Screening Upstream and Downstream Analysis
3.1 Blood Screening Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Blood Screening Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Blood Screening Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Blood Screening Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Blood Screening
5.3.2 Increased Demand in Emerging Markets
5.4 Blood Screening Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Blood Screening Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Grifols (Spain)
6.1.1 Grifols (Spain) Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Blood Screening Product Profiles, Application and Specification
6.1.3 Grifols (Spain) Blood Screening Market Performance (2017-2022)
6.1.4 Grifols (Spain) Business Overview
6.2 Abbott Laboratories (U.S.)
6.2.1 Abbott Laboratories (U.S.) Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Blood Screening Product Profiles, Application and Specification
6.2.3 Abbott Laboratories (U.S.) Blood Screening Market Performance (2017-2022)
6.2.4 Abbott Laboratories (U.S.) Business Overview
6.3 Roche Diagnostics (Switzerland)
6.3.1 Roche Diagnostics (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Blood Screening Product Profiles, Application and Specification
6.3.3 Roche Diagnostics (Switzerland) Blood Screening Market Performance (2017-2022)
6.3.4 Roche Diagnostics (Switzerland) Business Overview
6.4 Thermo Fisher Scientific, Inc. (U.S.)
6.4.1 Thermo Fisher Scientific, Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Blood Screening Product Profiles, Application and Specification
6.4.3 Thermo Fisher Scientific, Inc. (U.S.) Blood Screening Market Performance (2017-2022)
6.4.4 Thermo Fisher Scientific, Inc. (U.S.) Business Overview
6.5 BioM
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)